Bimala Dhakal

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Combination Therapy

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Bimala Dhakal, Yoko Tomita, Paul Drew, Timothy Price, Guy Maddern, Eric Smith, Kevin Aaron Fenix
Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects. Molecules (Basel, Switzerland) 28 (8) (2023)
Bimala Dhakal, Yoko Tomita, Paul Drew, Timothy Price, Guy Maddern, Eric Smith, Kevin Aaron Fenix
Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects. Molecules (Basel, Switzerland) 28 (8) (2023)
Bimala Dhakal, Yoko Tomita, Paul Drew, Timothy Price, Guy Maddern, Eric Smith, Kevin Aaron Fenix
Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects. Molecules (Basel, Switzerland) 28 (8) (2023)
Bimala Dhakal, Yoko Tomita, Paul Drew, Timothy Price, Guy Maddern, Eric Smith, Kevin Aaron Fenix
Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects. Molecules (Basel, Switzerland) 28 (8) (2023)
Bimala Dhakal, Celine Man Ying Li, Runhao Li, Kenny Yeo, Josephine A Wright, Krystyna A Gieniec, Laura Vrbanac, Tarik Sammour, Matthew Lawrence, Michelle Thomas, Mark Lewis, Joanne Perry, Daniel L Worthley, Susan L Woods, Paul Drew, Benedetta C Sallustio, Eric Smith, John D Horowitz, Guy John Maddern, Giovanni Licari, Kevin Aaron Fenix
The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing. Cancers 14 (4) (2022)